Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 20 de 209
Filtrar
1.
Public Health ; 199: 57-64, 2021 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-34560476

RESUMEN

OBJECTIVES: Unintentional poisoning was the leading cause of injury-related death in the United States in 2017. Prescribed and illicit drugs are the most common cause of poisoning, and timely management in the emergency department (ED) is important. Our aim was to identify any disparities in wait times associated with sex for drug poisoning-related ED visits. STUDY DESIGN: We examined ED visits using data from the 2009-2017 National Hospital Ambulatory Medical Care Survey (NHAMCS). METHODS: Drug poisoning-related visits were identified using the International Classification of Diseases, Ninth or Tenth Revision, Clinical Modification codes. Delayed assessment was defined as wait times exceeding the recommended triage time. Weighted logistic regression was used. RESULTS: The average age was 36 years (standard error = 1.1), 54% female, 87% White and 29% had delayed assessment. Most common drugs were psychotropics (45%) and opioids (32%). Adjusting for race, payment source, urgency, multiple drug types and NSAIDs, females who had poisoning by substances other than opioids had 2.1 times higher likelihood of having a delayed assessment compared with males (odds ratio [95% confidence interval]: 2.1 [1.03-4.2]), although there was no difference between sexes among visits with opioid poisoning (P = 0.27). Neither race (P = 0.23) nor payment source (P = 0.22) were associated with delayed assessment, and the sex association was consistent across these groups. CONCLUSIONS: Females with non-opioid drug poisoning were more likely to have delayed assessment than men. None of the other demographic factors demonstrated a correlation. Identifying more populations vulnerable to delays in the ED can help guide the development of interventions and policies to expedite care and attenuate existing disparities.


Asunto(s)
Servicio de Urgencia en Hospital , Preparaciones Farmacéuticas , Adulto , Analgésicos Opioides , Femenino , Encuestas de Atención de la Salud , Humanos , Clasificación Internacional de Enfermedades , Masculino , Estados Unidos/epidemiología
2.
Ir Med J ; 111(7): 791, 2018 08 13.
Artículo en Inglés | MEDLINE | ID: mdl-30520618

RESUMEN

Aim To present an interesting case of giant cell arteritis presenting as ischaemic upper limb. Methods Data was collected from the patient's chart and from radiology and laboratory systems in our institution. Results The patient had a temporal artery biopsy confirming the diagnosis of temporal arteritis. This was successfully treated with high dose steroids leading to resolution of symptoms in the arm. Conclusion Arteritis is an important consideration to consider in patients who present with limb ischaemia as it is a reversible cause which can be treated effectively.

4.
Am J Transplant ; 17(3): 617-621, 2017 03.
Artículo en Inglés | MEDLINE | ID: mdl-27696682

RESUMEN

There is substantial evidence across different healthcare contexts that social determinants of health are strongly associated with morbidity and mortality in the United States. These factors, including socioeconomic status, behavior and environmental risks, education, social support, healthy food, and access to healthcare also vary widely by region and individual communities. One of the implications of heterogeneity in these risks is the potential impact on measured quality of healthcare providers. In particular, there is concern that providers treating disproportionally vulnerable communities may be disadvantaged by lack of risk adjustment for these factors that affect health but not indicators of quality of care. Recently, the National Quality Forum has endorsed risk adjustment for sociodemographic characteristics based on these concerns. These issues are salient to transplant programs since social determinants of health impact transplant patient outcomes and vary by region. In this viewpoint, we argue that integration of ecological (area-level) factors in risk adjustment models used to assess transplant center quality should be strongly considered. We believe this reform could be accomplished rapidly, would attenuate disparities in access to care by reducing disincentives to treat patients from vulnerable communities, and improve risk adjustment and calibration of models used for center evaluations.


Asunto(s)
Trasplante de Órganos/estadística & datos numéricos , Evaluación de Programas y Proyectos de Salud , Medición de Riesgo , Clase Social , Obtención de Tejidos y Órganos , Humanos , Evaluación de Procesos y Resultados en Atención de Salud , Pronóstico , Sistema de Registros , Estados Unidos
5.
Ir Med J ; 108(3): 71-3, 2015 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-25876296

RESUMEN

Sleep related breathing disorders (SRBD) have historically been under-recognised and under-treated. Obstructive sleep apnoea (OSA) affects approximately 3% of children. In line with the increased recognition of SRBD there has been an increase in demand for diagnostic services. We determined the awareness of SRBD amongst Irish paediatricians, examined the provision of sleep services to children throughout the country between 2007 and 2011 and audited diagnostic sleep services in a tertiary centre in 2011. Amongst respondents there was an awareness of SRBD but a poor understanding of diagnostic evaluation with 31/46 (67) referring to inappropriate services. There has been a sharp increase in both diagnostic sleep tests (433-1793 [414]) and in the use of non-invasive ventilation (NIV) (31-186 [627]) for treatment of SRBD between 2007 and 2011. Paediatric sleep services are organized in an ad-hoc manner nationally with significant service variation. The use of domiciliary overnight oximetry reduced the requirement for more formal polysomnography by 70%.


Asunto(s)
Servicios de Diagnóstico/estadística & datos numéricos , Manejo de la Enfermedad , Síndromes de la Apnea del Sueño , Niño , Servicios de Salud del Niño/métodos , Servicios de Salud del Niño/estadística & datos numéricos , Técnicas de Diagnóstico del Sistema Respiratorio , Encuestas de Atención de la Salud , Necesidades y Demandas de Servicios de Salud , Humanos , Irlanda/epidemiología , Polisomnografía/estadística & datos numéricos , Prevalencia , Síndromes de la Apnea del Sueño/diagnóstico , Síndromes de la Apnea del Sueño/epidemiología , Síndromes de la Apnea del Sueño/etiología , Síndromes de la Apnea del Sueño/terapia
6.
J Small Anim Pract ; 65(2): 90-103, 2024 02.
Artículo en Inglés | MEDLINE | ID: mdl-38013167

RESUMEN

OBJECTIVES: This study used hydrogen nuclear magnetic resonance spectroscopy for the first time to examine differences in the metabolomic profile of stifle joint synovial fluid from dogs with cranial cruciate ligament rupture with and without meniscal injuries, in order to identify biomarkers of meniscal injury. Identifying a biomarker of meniscal injury could then ultimately be used to design a minimally invasive diagnostic test for meniscal injuries in dogs. MATERIALS AND METHODS: Stifle joint synovial fluid was collected from dogs undergoing stifle joint surgery or arthrocentesis for lameness investigations. We used multi-variate statistical analysis using principal component analysis and univariate statistical analysis using one-way analysis of variance and analysis of co-variance to identify differences in the metabolomic profile between dogs with cranial cruciate ligament rupture and meniscal injury, cranial cruciate ligament rupture without meniscal injury, and neither cranial cruciate ligament rupture nor meniscal injury, taking into consideration clinical variables. RESULTS: A total of 154 samples of canine synovial fluid were included in the study. Sixty-four metabolites were annotated to the hydrogen nuclear magnetic resonance spectroscopy spectra. Six spectral regions were found to be significantly altered (false discovery rate adjusted P-value <0.05) between groups with cranial cruciate ligament rupture with and without meniscal injury, including three attributed to nuclear magnetic resonance mobile lipids [mobile lipid -CH3 (P=0.016), mobile lipid -n(CH3 )3 (P=0.017), mobile unsaturated lipid (P=0.031)]. CLINICAL SIGNIFICANCE: We identified an increase in nuclear magnetic resonance mobile lipids in the synovial fluid of dogs with meniscal injury which are of interest as potential biomarkers of meniscal injury.


Asunto(s)
Lesiones del Ligamento Cruzado Anterior , Enfermedades de los Perros , Perros , Animales , Ligamento Cruzado Anterior/patología , Ligamento Cruzado Anterior/cirugía , Meniscos Tibiales/cirugía , Lesiones del Ligamento Cruzado Anterior/diagnóstico por imagen , Lesiones del Ligamento Cruzado Anterior/veterinaria , Rotura/veterinaria , Rotura/cirugía , Biomarcadores , Rodilla de Cuadrúpedos , Hidrógeno , Lípidos , Enfermedades de los Perros/diagnóstico , Enfermedades de los Perros/patología
8.
Reprod Sci ; 28(12): 3480-3490, 2021 12.
Artículo en Inglés | MEDLINE | ID: mdl-34524640

RESUMEN

Endometriosis is a common, chronic inflammatory condition, thought to have a higher incidence in symptomatic women, yet, commonly associated symptoms do not always correlate with the presence or severity of disease and diagnosis requires surgery. We prospectively collected data and assessed symptomology and NMR spectroscopy-based metabolomics of 102 women undergoing laparoscopic sterilisation at a tertiary referral centre in a cross-sectional study. Twelve women were incidentally diagnosed with endometriosis (11.7%). According to the pre-operative questionnaire, presence and absence of many symptoms usually attributed to endometriosis were declared at similar frequencies in women with or without endometriosis. Women with endometriosis reported apparently more persistent heavy periods (50% vs 18.9%), prolonged periods (25% versus 7.8%) and problems conceiving (27.3% versus 9%) than those without endometriosis. NMR could not discern any distinguishable differences in the serum metabolome between those with and without endometriosis. Our paper highlights the complex symptomology experienced by women, regardless of a surgical diagnosis of endometriosis. Previous literature and the current study failed to identify clear, distinguishable symptoms or biomarkers pertinent to surgically confirmed endometriosis in the general population. Therefore, development of effective, non-invasive tests for identifying this heterogenous benign condition, endometriosis, is likely to be challenging.


Asunto(s)
Endometriosis/sangre , Endometriosis/diagnóstico , Laparoscopía/métodos , Espectroscopía de Resonancia Magnética/métodos , Metabolómica/métodos , Esterilización Reproductiva/métodos , Adulto , Biomarcadores/sangre , Estudios de Cohortes , Estudios Transversales , Femenino , Humanos , Persona de Mediana Edad , Dolor Pélvico/sangre , Dolor Pélvico/diagnóstico , Valor Predictivo de las Pruebas , Estudios Prospectivos , Encuestas y Cuestionarios , Adulto Joven
9.
Equine Vet J ; 52(3): 384-390, 2020 May.
Artículo en Inglés | MEDLINE | ID: mdl-31657070

RESUMEN

BACKGROUND: Palmar osteochondral disease (POD) is a common cause of lameness in competition horses. Magnetic resonance imaging (MRI) is the most sensitive diagnostic modality currently available, however it may not be financially or logistically practical for routine screening of POD. There is increasing interest in the use of metabolomics for diagnosis prior to progression to irreversible damage. OBJECTIVES: To determine metabolite levels in synovial fluid (SF) of horses with a clinical diagnosis of POD based on diagnostic analgesia and MRI, with the hypothesis that metabolomic profiles differ between diseased and healthy joints. STUDY DESIGN: Prospective clinical study. METHODS: Synovial fluid was collected from metacarpo/tarsophalangeal joints (MC/TPJ) of 29 horses (n = 51 joints), including 14 controls (n = 26) and 15 cases (n = 25), the latter with lameness localised to the MC/TPJ and MR changes consistent with POD (n = 23). Spectra were produced using 1 H-nuclear magnetic resonance (NMR) spectroscopy and analysed. RESULTS: Twenty-five metabolites were recognised associated with various biosynthetic and degradation pathways. The metabolite abundances within the controls demonstrated increased variability compared with the clinical group. The low level of variance between the spectra of the two groups was explained by five principal components. Cross-validation of the cohort demonstrated modest separation of predictive power (R2  = 0.67; Q2  = 0.34). Although statistical significance was not achieved, the most influential metabolites were glucose and lactate. MAIN LIMITATIONS: The modest sample size and variation in signalment, background and presenting condition of the controls may have impacted the discriminative power of the constructed models. The lack of matched controls, differences in time of fluid collection and freezing times may have also reduced accuracy when representing metabolite profiles. CONCLUSIONS: This study identified and quantified metabolites present in MC/TPJ SF of clinical cases with POD.


Asunto(s)
Enfermedades de los Caballos , Líquido Sinovial , Animales , Caballos , Imagen por Resonancia Magnética , Metabolómica , Estudios Prospectivos
10.
Am J Transplant ; 9(2): 337-47, 2009 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-19067659

RESUMEN

We undertook this study to assess the rate of poor early graft function (EGF) after laparoscopic live donor nephrectomy (lapNx) and to determine whether poor EGF is associated with diminished long-term graft survival. The study population consisted of 946 consecutive lapNx donors/recipient pairs at our center. Poor EGF was defined as receiving hemodialysis on postoperative day (POD) 1 through POD 7 (delayed graft function [DGF]) or serum creatinine >/= 3.0 mg/dL at POD 5 without need for hemodialysis (slow graft function [SGF]). The incidence of poor EGF was 16.3% (DGF 5.8%, SGF 10.5%), and it was stable in chronologic tertiles. Poor EGF was independently associated with worse death-censored graft survival (adjusted hazard ratio (HR) 2.15, 95% confidence interval (CI) 1.34-3.47, p = 0.001), worse overall graft survival (HR 1.62, 95% CI 1.10-2.37, p = 0.014), worse acute rejection-free survival (HR 2.75, 95% CI 1.92-3.94, p < 0.001) and worse 1-year renal function (p = 0.002). Even SGF independently predicted worse renal allograft survival (HR 2.54, 95% CI 1.44-4.44, p = 0.001). Risk factors for poor DGF included advanced donor age, high recipient BMI, sirolimus use and prolonged warm ischemia time. In conclusion, poor EGF following lapNx has a deleterious effect on long-term graft function and survival.


Asunto(s)
Funcionamiento Retardado del Injerto/fisiopatología , Rechazo de Injerto/epidemiología , Supervivencia de Injerto/fisiología , Trasplante de Riñón/fisiología , Riñón/fisiopatología , Donadores Vivos , Nefrectomía , Adulto , Índice de Masa Corporal , Estudios de Cohortes , Creatinina/sangre , Femenino , Rechazo de Injerto/diagnóstico , Humanos , Incidencia , Laparoscopía , Masculino , Persona de Mediana Edad , Complicaciones Posoperatorias , Diálisis Renal , Factores de Riesgo , Recolección de Tejidos y Órganos , Trasplante Homólogo , Resultado del Tratamiento , Isquemia Tibia
11.
Clin Exp Rheumatol ; 27(4): 649-50, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19772799

RESUMEN

INTRODUCTION: I n order to assess the value of using the methotrexate information booklet, we conducted a single blind prospective controlled trial of the patients attending two rheumatology services. METHODS: The active-arm (n=40) used the MTX information booklet for the patients' education and the control-arm (n=38) did not. Patients' interviews were conducted over a 6-month period using an MTX-questionnaire. RESULTS: The entire active-arm patients (100%) were taking folic-acid and 32 (80%) knew the reason why they were taking folic-acid vs. [30 (79%) and 10 (26%) in the control-arm]. In the active-arm 35 (88%) knew the reason for their monthly blood tests vs. 18 (47%) in the control-arm. The entire active-arm was aware of the need for contraception use and MTX-side effects vs. 23 (60%) and 15 (40%) in the control-arm respectively. CONCLUSIONS: The use of the MTX information booklet in our cohort improved their understanding of the treatment.


Asunto(s)
Antirreumáticos/uso terapéutico , Artritis Reumatoide/tratamiento farmacológico , Metotrexato/uso terapéutico , Educación del Paciente como Asunto/métodos , Materiales de Enseñanza , Antirreumáticos/efectos adversos , Artritis Reumatoide/psicología , Ensayos Clínicos como Asunto , Femenino , Conocimientos, Actitudes y Práctica en Salud , Humanos , Entrevistas como Asunto , Masculino , Metotrexato/efectos adversos , Persona de Mediana Edad , Método Simple Ciego
13.
J Clin Invest ; 96(2): 1145-51, 1995 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-7635951

RESUMEN

The molecular defect in sickle cell disease resides in the beta globin gene, with consequent defects in erythrocytes only, suggesting that the vascular occlusion and vasomotor instability which characterize this disease are the result of interactions between abnormal sickle erythrocytes and cells of the blood vessel wall. We explored whether sickle erythrocytes may have effects on vascular tone, exclusive of adhesion events. Exposure of human endothelial cells in culture to previously sickled sickle erythrocytes resulted in a four to eight-fold transcriptional induction of the gene encoding the potent vasoconstrictor endothelin-1 (ET-1). Unsickled sickle erythrocytes or normal erythrocytes exposed to "sickling" conditions had no effect on ET-1 gene induction. Contact of the sickled erythrocytes with the endothelium was not required. Elevations in the ET-1 transcript peaked at 3 h after exposure and persisted for up to 24 h. Four to sixfold increases in the amount of ET-1 peptide was released into the medium surrounding the endothelial cells after exposure to sickled sickle erythrocytes. This is the first demonstration of the regulation of gene expression in endothelial cells as a result of interaction with sickle cells, with induction of genes encoding vasoconstrictors. Furthermore, these findings suggest that sickle erythrocytes may have the capacity to affect local vasomotor tone directly.


Asunto(s)
Anemia de Células Falciformes/fisiopatología , Hipoxia de la Célula , Endotelinas/genética , Endotelio Vascular/citología , Eritrocitos Anormales/fisiología , Regulación de la Expresión Génica , Precursores de Proteínas/genética , Anemia de Células Falciformes/sangre , Células Cultivadas , Endotelina-1 , Endotelinas/biosíntesis , Humanos , Precursores de Proteínas/biosíntesis , ARN Mensajero/metabolismo , Activación Transcripcional , Venas Umbilicales , Vasoconstricción/fisiología
14.
Mol Cell Biol ; 14(8): 5066-75, 1994 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-7913516

RESUMEN

Hox genes encode homeodomain-containing transcriptional regulators that function during development to specify positional identity along embryonic axes. The homeodomain is composed of a flexible N-terminal arm and three alpha helices, and it differentially binds DNA. A number of homeodomains recognize sites containing a TAAT core motif. The product of the murine Hoxd-4 (Hox-4.2) gene functions in a positive autoregulatory fashion in P19 cells that is dependent on two TAAT motifs in the Hoxd-4 promoter. This effect is specific in that murine HOXA-1 (HOX-1.6) is unable to activate transcription through the Hoxd-4 autoregulatory element. Here we show that this is due to an inability of the HOXA-1 homeodomain to bind a HOXD-4 recognition site effectively. We have produced chimeras between HOXD-4 and HOXA-1 to map specific residues responsible for this functional difference. When positions 2 and 3 in the N-terminal arm of HOXA-1 were converted to HOXD-4 identity, both strong DNA binding and transcriptional activation were rescued. This substitution appears to confer an increased DNA-binding ability on the HOXA-1 homeodomain, since we were unable to detect a high-affinity recognition sequence for HOXA-1 in a randomized pool of DNA probes. The contribution of position 3 to DNA binding has been implicated by structural studies, but this is the first report of the importance of position 2 in regulating homeodomain-DNA interactions. Additionally, specific homeodomain residues that confer major differences in DNA binding and transcriptional activation between Hox gene products have not been previously determined. Identity at these two positions is generally conserved among paralogs but varies between Hox gene subfamilies. As a result, these residues may be important for the regulation of target gene expression by specific Hox products.


Asunto(s)
Proteínas de Unión al ADN/química , Regulación de la Expresión Génica , Genes Homeobox , Factores de Transcripción/química , Factores de Transcripción/genética , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Ratones , Datos de Secuencia Molecular , Sondas de Oligonucleótidos/química , Proteínas Recombinantes de Fusión , Relación Estructura-Actividad , Activación Transcripcional
15.
Mol Cell Biol ; 20(17): 6380-9, 2000 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-10938115

RESUMEN

Chromatin remodeling complexes help regulate the structure of chromatin to facilitate transcription. The multisubunit human (h) SWI-SNF complex has been shown to remodel mono- and polynucleosome templates in an ATP-dependent manner. The isolated hSWI-SNF ATPase subunits BRG1 and hBRM also have these activities. The intact complex has been shown to produce a stable remodeled dimer of mononucleosomes as a product. Here we show that the hSWI-SNF ATPases alone can also produce this product. In addition, we show that hSWI-SNF and its ATPases have the ability to transfer histone octamers from donor nucleosomes to acceptor DNA. These two reactions are characterized and compared. Our results are consistent with both products of SWI-SNF action being formed as alternative outcomes of a single remodeling mechanism. The ability of the isolated ATPase subunits to catalyze these reactions suggests that these subunits play a key role in determining the mechanistic capabilities of the SWI-SNF family of remodeling complexes.


Asunto(s)
Adenosina Trifosfatasas/metabolismo , Proteínas de Ciclo Celular , Cromatina/metabolismo , Nucleosomas/metabolismo , Factores de Transcripción/química , Factores de Transcripción/metabolismo , Adenosina Trifosfato/metabolismo , ADN/metabolismo , ADN Helicasas , Dimerización , Proteínas de Drosophila , Células HeLa , Histonas/metabolismo , Humanos , Cloruro de Magnesio/farmacología , Modelos Biológicos , Proteínas Nucleares/metabolismo , Plásmidos/metabolismo , Cloruro de Potasio/farmacología , Factores de Tiempo , Transactivadores/metabolismo
16.
Mol Cell Biol ; 15(8): 3989-97, 1995 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-7623795

RESUMEN

Homeoprotein products of the Hox/HOM gene family pattern the animal embryo through the transcriptional regulation of target genes. We have previously shown that the labial group protein HOXA-1 has intrinsically weak DNA-binding activity due to residues in the N-terminal arm of its homeodomain (M. L. Phelan, R. Sadoul, and M. S. Featherstone, Mol. Cell. Biol. 14:5066-5075, 1994). This observation, among others, suggests that HOX and HOM proteins require cofactors for stable interactions with DNA. We have demonstrated that a putative HOX cofactor, PBX1A, participates in cooperative DNA binding with HOXA-1 and the Deformed group protein HOXD-4. Three Abdominal-B class HOX proteins failed to cooperate with PBX1A. We mapped the interacting domain of HOXD-4 to the YPWMK pentapeptide motif, a conserved sequence found N terminal to the homeodomain of HOXA-1 and many other homeoproteins but absent from the Abdominal-B class. The naturally occurring fusion of the transcriptional activation domain of E2A with PBX1 creates an oncoprotein implicated in human pre-B-cell leukemias (M. P. Kamps, C. Murre, X.-H. Sun, and D. Baltimore, Cell 60:547-555, 1990; J. Nourse, J. D. Mellentin, N. Galili, J. Wilkinson, E. Starbridge, S. D. Smith, and M. L. Cleary, Cell 60:535-545, 1990). A pentapeptide mutation that abolished cooperative interaction with PBX1A in vitro also abrogated synergistic transcriptional activation with the E2A/PBX oncoprotein. The direct contact of PBX family members by the HOX pentapeptide is likely to play an important role in developmental and oncogenic processes.


Asunto(s)
Secuencia Conservada , Proteínas de Unión al ADN/metabolismo , ADN/metabolismo , Proteínas de Homeodominio/metabolismo , Fragmentos de Péptidos/metabolismo , Proteínas Proto-Oncogénicas/metabolismo , Transcripción Genética , Secuencia de Aminoácidos , Secuencia de Bases , Regulación Neoplásica de la Expresión Génica , Proteínas de Homeodominio/genética , Humanos , Datos de Secuencia Molecular , Proteínas de Fusión Oncogénica/metabolismo , Factor de Transcripción 1 de la Leucemia de Células Pre-B , Unión Proteica , Conformación Proteica , Factores de Transcripción/genética , Factores de Transcripción/metabolismo , Células Tumorales Cultivadas
17.
Mol Cell Biol ; 20(20): 7541-9, 2000 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-11003650

RESUMEN

Several factors that mediate activation by nuclear receptors also modify the chemical and structural composition of chromatin. Prominent in this diverse group is the steroid receptor coactivator 1 (SRC-1) family, which interact with agonist-bound nuclear receptors, thereby coupling them to multifunctional transcriptional coregulators such as CREB-binding protein (CBP), p300, and PCAF, all of which have potent histone acetyltransferase activity. Additionally factors including the Brahma-related gene 1 (BRG-1) that are involved in the structural remodeling of chromatin also mediate hormone-dependent transcriptional activation by nuclear receptors. Here, we provide evidence that these two distinct mechanisms of coactivation may operate in a collaborative manner. We demonstrate that transcriptional activation by the estrogen receptor (ER) requires functional BRG-1 and that the coactivation of estrogen signaling by either SRC-1 or CBP is BRG-1 dependent. We find that in response to estrogen, ER recruits BRG-1, thereby targeting BRG-1 to the promoters of estrogen-responsive genes in a manner that occurs simultaneous to histone acetylation. Finally, we demonstrate that BRG-1-mediated coactivation of ER signaling is regulated by the state of histone acetylation within a cell. Inhibition of histone deacetylation by trichostatin A dramatically increases BRG-1-mediated coactivation of ER signaling, and this increase is reversed by overexpression of histone deacetylase 1. These studies support a critical role for BRG-1 in ER action in which estrogen stimulates an ER-BRG-1 association coupling BRG-1 to regions of chromatin at the sites of estrogen-responsive promoters and promotes the activity of other recruited factors that alter the acetylation state of chromatin.


Asunto(s)
Estrógenos/farmacología , Histonas/metabolismo , Proteínas Nucleares/metabolismo , Regiones Promotoras Genéticas/genética , Receptores de Estrógenos/metabolismo , Elementos de Respuesta/genética , Factores de Transcripción/metabolismo , Acetilación/efectos de los fármacos , Proteína de Unión a CREB , Cromatina/química , Cromatina/genética , Cromatina/metabolismo , ADN Helicasas , Proteínas de Unión al ADN/metabolismo , Histona Acetiltransferasas , Histona Desacetilasas/metabolismo , Histonas/química , Humanos , Ácidos Hidroxámicos/farmacología , Ligandos , Coactivador 1 de Receptor Nuclear , Unión Proteica/efectos de los fármacos , Transducción de Señal/efectos de los fármacos , Transactivadores/metabolismo , Activación Transcripcional/efectos de los fármacos , Células Tumorales Cultivadas
18.
Clin Rheumatol ; 26(9): 1439-43, 2007 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-17235655

RESUMEN

We assessed investigations and management protocols for patients starting long-term steroid therapy. Rheumatology, respiratory, hematology, oncology, and gastroenterology consultants were asked five questions designed to assess investigation and management protocols followed in dealing with 50-year-old male, 25- and 75-year-old female patients. The response rates were as follows: rheumatologists 11/14 (78.6%), gastroenterologists 19/31 (61.3%), respiratory physicians 13/26 (50%), hematologists 10/25 (40%), oncologists 6/21 (28.6%). In 50-year-old men, calcium + vitamin D was recommended by 6/11 (54.54%) rheumatologists, 7/13 (53.84%) respiratory physicians, 5/10 (50%) hematologists, 2/6 (33.33%) oncologists, and 13/19 (68.42%) gastroenterologists. Bisphosphonates were recommended by 3/11 (27.22%) rheumatologists, 8/13 (61.53%) respiratory physicians, 2/10 (20%) hematologists, and 5/19 (26.31%) gastroenterologists. Bone densitometry was considered by 4/11 (36.36%) rheumatologist, 3/13 (23.07%) respiratory physicians, 2/10 (20%) hematologists, 8/19 (42.10%) gastroenterologists. Calcium, phosphate, and alkaline phosphate were checked by 3/11 (27.27%) rheumatologists, 3/13 (23.07%) respiratory physicians, 2/10 (20%) hematologists, 3/6 (50%) oncologists, 6/19 (31.57%) gastroenterologists. In 25-year-old women, 4/11 (36.37%) rheumatologists, 3/13 (23.07%) respiratory physicians, 2/10 (20%) hematologists, 1/6 (16.66%) oncologists, and 4/19 (21.05%) gastroenterologists considered bone densitometry. Calcium, phosphate, and alkaline phosphatase were checked by 3/11 (27.27%) rheumatologists, 1/13 (07.69%) respiratory physicians, 3/10 (30%) hematologists, 3/6 (50%) oncologists, and 6/19 (31.57%) gastroenterologists. Calcium + vitamin D treatment was favored by 8/11 (72.72%) rheumatologists, 8/13 (61.51%) respiratory physicians, 5/10 (50%) hematologists, 2/6 (33.33%) oncologists, 14/19 (73.68%) gastroenterologists. Bisphosphonates were considered by 2/18 (18.18%) rheumatologists, 6/13 (46.15%) respiratory physicians, 1/10 (10%) hematologists, 1/6 (16.66%) oncologists, and 3/19 (15.78%) gastroenterologists. In 70-year-old women, calcium + vitamin D was recommended by 8/11 (72.72%) rheumatologists, 9/13 (69.23%) respiratory physicians, 5/10 (50%) hematologists, 2/6 (33.33%) oncologists, and 15/19 (78.94%) gastroenterologists. Bisphosphonates were considered by 9/11 (81.81%) rheumatologists, 13/13 (100%) respiratory physicians, 9/10 (90%) hematologists, 2/6 (33.33%) oncologists, and 18/19 (94.73%) gastroenterologists. Reloxifene was considered by 4/11 (36.36%) rheumatologists and 2/6(33.33%) oncologists. This survey demonstrates the lack of consensus in investigating and treating male and young female patients at risk, exceptions being elderly women.


Asunto(s)
Antiinflamatorios/efectos adversos , Osteoporosis/inducido químicamente , Pautas de la Práctica en Medicina/estadística & datos numéricos , Enfermedades Reumáticas/tratamiento farmacológico , Esteroides/efectos adversos , Adulto , Anciano , Recolección de Datos , Femenino , Hospitales Públicos/estadística & datos numéricos , Humanos , Irlanda , Masculino , Persona de Mediana Edad , Osteoporosis/tratamiento farmacológico , Osteoporosis/prevención & control , Guías de Práctica Clínica como Asunto
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda